About Lucid Diagnostics Inc. - Common Stock (LUCD)
Lucid Diagnostics Inc is a technology company focused on advancing the field of diagnostic solutions in healthcare. It specializes in the development and commercialization of innovative medical devices and diagnostic tests aimed at improving patient outcomes and streamlining the detection of various diseases, particularly in the gastrointestinal sector. The company is committed to creating impactful tools that enhance the efficiency and accuracy of disease diagnosis, thereby supporting healthcare professionals in delivering better care to patients. Its portfolio includes both proprietary technologies and collaborations aimed at bringing cutting-edge diagnostics to the market. Read More
Lucid Diagnostics (NASDAQ:LUCD) reported first-quarter 2026 EsoGuard test volume above its pre-Medicare target range, while management said it continues to await a Medicare local coverage determination and is expanding efforts with the Department of Veterans Affairs, commercial payers and health sys
The company’s subsidiary, Lucid Diagnostics, secured a contract from the U.S. Department of Veterans Affairs to provide its EsoGuard Esophageal DNA Test for the detection of esophageal precancer.
Stay up-to-date with the latest market trends one hour before the close of the markets on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
